HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Lloyd S Miller Selected Research
Lloyd S Miller Research Topics
Disease
48
Infections
08/2023 - 03/2002
16
Inflammation (Inflammations)
01/2023 - 09/2010
9
Psoriasis (Pustulosis Palmaris et Plantaris)
01/2023 - 05/2005
8
Staphylococcal Infections
01/2023 - 05/2010
6
Wounds and Injuries (Trauma)
11/2021 - 07/2008
5
Skin Diseases (Skin Disease)
01/2023 - 01/2008
4
Dermatitis
01/2023 - 01/2018
3
Soft Tissue Infections
01/2023 - 05/2010
3
Wound Infection (Wound Infections)
10/2022 - 04/2011
3
Abscess
01/2022 - 03/2012
3
Persistent Infection
01/2018 - 03/2012
2
Autoimmune Diseases (Autoimmune Disease)
01/2023 - 01/2018
2
Atopic Dermatitis (Atopic Eczema)
01/2023 - 01/2021
2
Dysbiosis
01/2022 - 01/2019
2
Bacterial Infections (Bacterial Infection)
01/2022 - 12/2012
2
Asthma (Bronchial Asthma)
01/2021 - 12/2018
2
Infectious Arthritis (Septic Arthritis)
01/2020 - 01/2017
2
Osteomyelitis
01/2020 - 01/2017
2
Muscle Cramp (Cramp)
01/2017 - 12/2016
1
Erythema
01/2023
1
Bacteremia
10/2022
1
Allergic Rhinitis
01/2021
1
Food Hypersensitivity (Food Allergy)
01/2021
1
Malaria
01/2021
1
Pneumonia (Pneumonitis)
01/2021
1
Disease Progression
01/2020
1
Coinfection
11/2019
1
Drug Eruptions (Drug Eruption)
09/2019
1
Communicable Diseases (Infectious Diseases)
01/2019
Drug/Important Bio-Agent (IBA)
27
Anti-Bacterial Agents (Antibiotics)
IBA
08/2023 - 05/2010
11
Interleukin-17 (Interleukin 17)
IBA
01/2023 - 05/2010
8
Cytokines
IBA
01/2023 - 11/2010
5
Interleukin-22 (IL-22)
IBA
01/2022 - 11/2010
5
Rifampin (Rifampicin)
FDA Link
Generic
12/2021 - 09/2010
4
Imiquimod (Aldara)
FDA Link
Generic
01/2023 - 01/2018
4
Vaccines
IBA
01/2021 - 12/2018
4
Proteins (Proteins, Gene)
FDA Link
11/2019 - 07/2008
4
Titanium
IBA
01/2018 - 01/2012
4
Vancomycin
FDA Link
Generic
07/2016 - 05/2012
3
Interleukin-23 (Interleukin 23)
IBA
01/2022 - 11/2010
3
Antimicrobial Peptides
IBA
01/2020 - 03/2012
3
Monoclonal Antibodies
IBA
01/2019 - 01/2017
2
Caspases
IBA
08/2023 - 01/2021
2
Filaggrin Proteins
IBA
01/2023 - 01/2019
2
Linezolid (Zyvox)
FDA Link
10/2022 - 04/2017
2
Interleukin-4 (Interleukin 4)
IBA
11/2021 - 01/2021
2
RNA (Ribonucleic Acid)
IBA
11/2021 - 01/2020
2
Fluorescent Dyes (Fluorescent Probes)
IBA
01/2021 - 11/2019
2
DNA (Deoxyribonucleic Acid)
IBA
01/2020 - 03/2002
2
Antigens
IBA
01/2019 - 10/2012
2
Virulence Factors (Pathogenicity Factors)
IBA
11/2017 - 01/2017
2
Interferon-gamma (Interferon, gamma)
IBA
01/2017 - 11/2015
2
Anti-Infective Agents (Microbicides)
IBA
11/2016 - 02/2013
2
Chemokines
IBA
10/2016 - 07/2011
2
Tigecycline (Tygacil)
FDA Link
07/2016 - 05/2012
2
Polymers
IBA
07/2016 - 09/2010
2
Interleukin-1 (Interleukin 1)
IBA
04/2012 - 07/2011
1
Doxycycline (Periostat)
FDA Link
Generic
08/2023
1
3- (2- (2- tert- butylphenylaminooxalyl)aminopropionylamino)- 4- oxo- 5- (2,3,5,6- tetrafluorophenoxy)pentanoic acid
IBA
08/2023
1
Autoantibodies
IBA
01/2023
1
crisaborole
IBA
01/2023
1
Phosphodiesterase 4 Inhibitors
IBA
01/2023
1
Phosphodiesterase Inhibitors
IBA
01/2023
1
Adenylyl Cyclases (Adenylyl Cyclase)
IBA
01/2023
1
Cyclic AMP (AMP, Cyclic)
IBA
01/2023
1
Placebos
IBA
10/2022
1
Oxazolidinones (2 Oxazolidone)
IBA
10/2022
1
butyl phosphorotrithioate (DEF)
IBA
01/2022
1
Chemokine Receptors
IBA
01/2022
1
Janus Kinase Inhibitors
IBA
01/2022
1
Defensins
IBA
01/2022
1
interleukin-21 (interleukin 21)
IBA
01/2022
1
STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)
IBA
01/2022
1
tofacitinib
IBA
01/2022
1
Interleukin-6 (Interleukin 6)
IBA
01/2022
1
quinoline
IBA
01/2021
1
staphylococcus IsaA antigen
IBA
01/2021
1
quinoline-val-asp(OMe)-CH2-OPH
IBA
01/2021
1
Allergens
IBA
01/2021
1
Aspartic Acid (Aspartate)
FDA Link
01/2021
1
Immunoglobulin E (IgE)
IBA
01/2021
1
Ketones
IBA
01/2021
1
Peptidoglycan (Murein)
IBA
01/2021
1
Valine (L-Valine)
FDA Link
01/2021
1
Therapeutic Uses
IBA
01/2021
1
SNARE Proteins (SNAREs)
IBA
01/2021
1
Vesicle-Associated Membrane Protein 2 (VAMP2)
IBA
01/2021
1
Antibodies
IBA
01/2020
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2020
1
Luciferases
IBA
11/2019
1
Sorafenib (BAY 43-9006)
FDA Link
09/2019
1
Interferon Type I
IBA
01/2019
1
Antimicrobial Cationic Peptides
IBA
01/2019
Therapy/Procedure
15
Therapeutics
08/2023 - 01/2008
4
Immunotherapy
08/2023 - 01/2020
4
Arthroplasty
07/2016 - 09/2010
2
Debridement
01/2021 - 02/2019
2
Prostheses and Implants (Prosthesis)
01/2018 - 11/2016
1
Injections
11/2019
1
Computer-Assisted Surgery (Image Guided Surgery)
02/2019